Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy

• Status: Completed
• Trial end date: 2012-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study was to evaluate the effects of dexmedetomidine on renal function, hormonal and hemodynamic parameters in contrast media induced diabetic patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: TC Erciyes University
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• Scheduled for percutaneous coronary angiography

• > 18 yo

• Diabetic patients

• Creatinin value < 3 mg/dl

Exclusion Criteria:

• Contrast agent hypersensitivity

• Pregnant patients

• Creatinin value ≥3mg/dl

• patients have acute renal failure